SCI Abstract

search
+
Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study
Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study
Abstract Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liv...
Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States
Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States
ABSTRACT We investigated factors associated with rates of recommended monitoring of chronic hepatitis B (HBV) patients for...
Adenovirus vector encoding TPPII ignites HBV‐specific CTL response by activating autophagy in CD8+T cell
Adenovirus vector encoding TPPII ignites HBV‐specific CTL response by activating autophagy in CD8+T cell
Abstract Early studies have shown that autophagy and TPPII are associated with HBV infection. In this study, adenovirus ve...
Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: a multicenter cohort study
Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: a multicenter cohort study
Abstract Liver steatosis is becoming increasingly common in patients with chronic hepatitis B (CHB), and its effect on liv...
The Impact of the First, Second, and Third Waves of COVID‐19 on Hepatitis B and C Testing in Ontario, Canada
The Impact of the First, Second, and Third Waves of COVID‐19 on Hepatitis B and C Testing in Ontario, Canada
Abstract The COVID-19 pandemic interrupted routine healthcare services. Hepatitis B virus (HBV) and hepatitis C virus (HCV...
Intrahepatic immune infiltrate in chronic hepatitis B and chronic hepatitis C: Similar but not the same
Intrahepatic immune infiltrate in chronic hepatitis B and chronic hepatitis C: Similar but not the same
ABSTRACT In chronic hepatitis B (CHB) and C (CHC) infections the composition of the immune cell microenvironment at the si...
Contextual and Individual Factors Associated with Knowledge, Awareness, and Attitude on Liver Diseases: A Large‐scale Asian Study
Contextual and Individual Factors Associated with Knowledge, Awareness, and Attitude on Liver Diseases: A Large‐scale Asian Study
Abstract There is limited data to provide better understanding of the knowledge/awareness of general population toward liv...
Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination
Abstract Hepatitis C Virus (HCV) causes a significant health and economic burden and reduces patients’ quality of l...
Improving disease knowledge is critical to eliminate hepatitis B
Improving disease knowledge is critical to eliminate hepatitis B
Abstract Despite its high burden of disease, viral hepatitis B has been long neglected and still receives little public at...
A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC trial)
A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP‐HEPC trial)
Abstract The availability of direct-acting antivirals (DAAs) sparked efforts to eliminate hepatitis C virus (HCV) in Austr...
Electronic Nose versus Quadrupole Mass Spectrometry for Identifying Viral Hepatitis C Patients
Electronic Nose versus Quadrupole Mass Spectrometry for Identifying Viral Hepatitis C Patients
Abstract Hepatitis C is a leading cause of liver disease and transplantation and is a major burden on public health worldw...
A cluster randomised controlled trial of a MedicineInsight Educational QUality Improvement Program to improve the diagnosis and treatment of chronic HEPatitis C in general practice (the EQUIP‐HEPC trial)
A cluster randomised controlled trial of a MedicineInsight Educational QUality Improvement Program to improve the diagnosis and treatment of chronic HEPatitis C in general practice (the EQUIP‐HEPC trial)
Abstract The availability of direct acting antivirals (DAAs) sparked efforts to eliminate hepatitis C virus (HCV) in Austr...
A risk scoring system to predict clinical events in chronic hepatitis B virus infection: a nationwide cohort study
A risk scoring system to predict clinical events in chronic hepatitis B virus infection: a nationwide cohort study
Abstract Many patients with chronic hepatitis B do not receive adequate follow-up. This study aimed to develop a risk scor...
Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment
Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment
Abstract Hepatocellular carcinoma (HCC) has high recurrence rates. HCC sometimes progresses from early-stage HCC (Barcelon...
Kinetics of Hepatitis B Surface Antigen in Pregnant Women with and without Tenofovir Disoproxil Fumarate
Kinetics of Hepatitis B Surface Antigen in Pregnant Women with and without Tenofovir Disoproxil Fumarate
Abstract Tenofovir disoproxil fumarate (TDF) is the preferred treatment to prevent mother-to-infant transmission in highly...
Role of peer support in a hepatitis C elimination programme
Role of peer support in a hepatitis C elimination programme
Abstract Many people with chronic hepatitis C infection don't engage in treatment. To eliminate hepatitis C and avoid heal...
Direct‐Acting Antivirals Reduce the Risk of Tumor Progression of Hepatocellular Carcinoma after Curative Treatment
Direct‐Acting Antivirals Reduce the Risk of Tumor Progression of Hepatocellular Carcinoma after Curative Treatment
Abstract Hepatocellular carcinoma (HCC) has high recurrence rates. HCC sometimes progresses from early-stage HCC (Barcelon...
Role of peer support in a hepatitis C elimination program
Role of peer support in a hepatitis C elimination program
Abstract Many people with chronic hepatitis C infection don’t engage in treatment. To eliminate hepatitis C and avo...
Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment
Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment
Abstract Direct acting antivirals (DAAs) have recently been developed to treat hepatitis C virus (HCV) infection, and inte...
Derivation and validation of prognostic models for predicting survival outcomes in Acute‐on‐chronic liver failure patients
Derivation and validation of prognostic models for predicting survival outcomes in Acute‐on‐chronic liver failure patients
Abstract Acute-on-chronic liver failure (ACLF) is a syndrome characterized by acute decompensation of chronic liver diseas...
Factors affecting long‐term changes of liver stiffness in direct‐acting anti‐hepatitis C virus therapy: A multicentre prospective study
Factors affecting long‐term changes of liver stiffness in direct‐acting anti‐hepatitis C virus therapy: A multicentre prospective study
Abstract The long-term changes of liver stiffness (LS) in patients who achieve viral clearance after direct-acting anti-HC...
Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal
Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal
Abstract Chronic hepatitis B virus (HBV) infection affects >10% of the general population and is the leading cause of l...
Non‐invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)‐associated liver disease and sustained virologic response (SVR): 3 years follow‐up of a prospective longitudinal study
Non‐invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)‐associated liver disease and sustained virologic response (SVR): 3 years follow‐up of a prospective longitudinal study
Abstract Long-term effects on cirrhosis and portal hypertension of direct antiviral agent (DAA)-based eradication of hepat...
Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: a cohort study
Associated screening for HCV and SARS‐Cov2 infection in an urban area of Southern Italy: a cohort study
Abstract Background and aims The SARS-Cov2 pandemic led to reorganize the clinical activities in Italy, reducing the avail...
Acute Delta Hepatitis in Italy spanning three decades (1991‐2019): evidence for the effectiveness of the hepatitis B vaccination campaign
Acute Delta Hepatitis in Italy spanning three decades (1991‐2019): evidence for the effectiveness of the hepatitis B vaccination campaign
Abstract Updated incidence data of acute Delta virus hepatitis (HDV) are lacking worldwide. Our aim was to evaluate incide...
Efficacy of an eConsult Service to Cure Hepatitis C in Primary Care
Efficacy of an eConsult Service to Cure Hepatitis C in Primary Care
Abstract In 2016, an eConsult service was developed within a safety net health system to expand access to hepatitis C (HCV...
Psychiatrists can treat hepatitis C
Psychiatrists can treat hepatitis C
Abstract We read the article by Harney and colleagues with interest1. Harney presents a model of nurse-led hepatitis C tre...
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt
Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta, Egypt
Abstract The epidemiology of HDV infection worldwide is obscure. Mapping the epidemiology of the infection is highly requi...
Liver fibrosis scores and risk of liver‐related mortality in young adults with chronic hepatitis B: A cohort study
Liver fibrosis scores and risk of liver‐related mortality in young adults with chronic hepatitis B: A cohort study
Abstract The predictive role of noninvasive liver fibrosis scores on liver-related mortality in patients with chronic hepa...
Letter in response: Psychiatrists can treat hepatitis C
Letter in response: Psychiatrists can treat hepatitis C
Abstract In our recent paper (1) we reported hepatitis C virus (HCV) treatment outcomes among people attending a co-locate...
Load More
format_indent_increase